China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Escitalopram Before Surgery and With Neoadjuvant Chemoimmunotherapy in Resectable Lung Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136698
Registration Time: 2026/11/13
Type: Interventional study
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349581
Published by HT Digital Content Services with permission from Health Daily Digest....